4 47346452221Reads by AI crawlersClaude0ChatGPT3Google · Gemini0Perplexity4Meta AI6Microsoft · Copilot4Amazon5Apple2China (ByteDance, Huawei, Baidu…)2ByteDance (Doubao)2Others21Total47Counted by the name each crawler declares; requests found to be impersonating one are left out. Google · Gemini includes Googlebot, the search crawler whose index Google also uses for its AI features. Other search engines and bots are under Others.
A small minority of people infected with HIV-1 keep the virus suppressed for years without treatment -- "controllers." A landmark 2010 study found the reason sits almost entirely in how well a person's immune system can show viral fragments to itself.
What this condition connects to
Prevalence
HIV controllers are a small minority of people living with HIV-1; estimates commonly cited in the research literature put elite controllers (undetectable viral load without treatment) at well under 1% of infected people. The genetic study behind this page compared a multiethnic cohort of controllers against progressors (International HIV Controllers Study, Science 2010, PMID:21051598).
Inheritance
Concentrated almost entirely in one genomic region: more than 300 genome-wide-significant SNPs in the major histocompatibility complex, explained largely by specific amino acid positions in the HLA-B peptide-binding groove plus an independent HLA-C effect -- one underlying mechanism (antigen presentation), not many separate genes.
Most people infected with HIV-1, left untreated, progress toward AIDS over years as the virus steadily damages the immune system. A small minority do not: HIV controllers keep the virus suppressed to very low or even undetectable levels for years, without antiretroviral treatment, through their own immune response. Understanding why has been one of HIV research's central questions, since it points directly at what a vaccine or cure would need to reproduce.
Over 300 signals, and one real mechanism behind almost all of them
A 2010 genome-wide association study compared a multiethnic cohort of HIV controllers against progressors and found more than 300 genome-wide-significant SNPs — but nearly all of them concentrated in one region: the major histocompatibility complex (MHC), the genomic neighborhood that encodes HLA molecules. Rather than stopping at a list of associated positions, the study went further and found what actually explains them: specific amino acid positions in the HLA-B peptide-binding groove — the physical pocket an HLA-B molecule uses to grab a fragment of viral protein and display it on the cell surface for immune cells to recognize — plus an independent effect from HLA-C. Together, these reconciled both the protective and the risk-associated HLA alleles into one mechanism: how effectively a person's HLA molecules present HIV peptides for the immune system to act on, not many separate genes each doing something different.
This page holds 5 of this study's variants: one directly in HLA-B, one near MICB, one near MUC22, and two in or near MICA — a gene that sits physically next to HLA-B on chromosome 6 and is frequently co-inherited with it, part of the same broad MHC signal the study traced back to HLA-B's peptide-binding groove.
Clinical detail
What is actually diagnosed and treated here
HIV-1 infection and viral load are diagnosed and monitored by blood tests, not genotype. None of the 5 variants on this page are used by any guideline to diagnose HIV, predict who will become a controller, or replace antiretroviral treatment.
The findings described above come from a research cohort of already-infected people compared against each other, not a general-population risk score. They explain a large share of why some people control HIV-1 without treatment and others do not — genuinely important for vaccine and cure research — but they are not a way to predict an uninfected person's future response to the virus, and controller status itself does not mean the virus is gone or that treatment is unnecessary.
Related variants MyGeneLog™ checks for
What a 23andMe/AncestryDNA export or raw VCF can and can't tell you about HIV-1 Viral Control comes down to these specific, well-studied positions — not a diagnosis.
The studies behind these variants recruited participants from different ancestries — a result found in one population doesn't always transfer to another. Based on 5 of 5 linked studies with a resolved discovery ancestry.
100.0%
Other named ancestries (Hispanic or Latin American, African American or Afro-Caribbean) · 100.0%
4 47346452221Reads by AI crawlersClaude0ChatGPT3Google · Gemini0Perplexity4Meta AI6Microsoft · Copilot4Amazon5Apple2China (ByteDance, Huawei, Baidu…)2ByteDance (Doubao)2Others21Total47Counted by the name each crawler declares; requests found to be impersonating one are left out. Google · Gemini includes Googlebot, the search crawler whose index Google also uses for its AI features. Other search engines and bots are under Others.
Quoting this page
Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.
An HIV controller is someone infected with HIV-1 whose immune system keeps the virus suppressed to very low or undetectable levels for years without antiretroviral treatment -- a small minority of people living with HIV.
What did the 2010 study find explains HIV-1 control?
More than 300 genome-wide-significant SNPs, nearly all concentrated in the major histocompatibility complex. The study traced this back to specific amino acid positions in the HLA-B peptide-binding groove, plus an independent HLA-C effect -- one mechanism (how well HLA molecules present viral fragments to the immune system) explaining both protective and risk-associated HLA alleles.
Is this the same as CCR5-delta32 resistance to HIV?
No -- a genuinely different mechanism. CCR5-delta32 blocks the virus from entering cells in the first place, covered on this site's own CCR5-delta32 page. This page is about people already infected whose immune systems, largely through HLA-B and HLA-C, keep the virus suppressed afterward.
Can these variants predict whether someone will become a controller?
Not for an individual. These are findings from comparing already-infected controllers against progressors in a research cohort, not a validated predictive test, and they do not replace HIV testing, viral load monitoring or antiretroviral treatment.
Free to reuse. This page's text is original writing from freely-available research, licensed CC BY 4.0 — reuse it, including commercially, with attribution to MyGeneLog™. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.